My colleague Vikas Dandekar, Pharmasianews bureau chief in India, recently tweeted the following comments from GSK CEO Andrew Witty (at an investor call). "I'm not paying 37 times earnings for an Indian company, I am just not." "We are going to walk away from opportunities that go out of our price range, and where we … Continue reading GSK’s Witty does some tough talk on India M&A
Tag: andrew witty
GSK’s Andrew Witty takes next steps after patent pool
Andrew Witty, CEO of UK's GlaxoSmithKline said recently on a conference call that his company will publish chemical structures of 13,500 compounds that are seen to be active against the key parasite that causes malaria and all related knowledge about them on public websites for scientists. GSK has a 2 million-strong library of compounds - essentially building blocks of … Continue reading GSK’s Andrew Witty takes next steps after patent pool